Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$564M |
| 2 |
UnitedHealth
UNH
|
$439M |
| 3 |
Johnson & Johnson
JNJ
|
$353M |
| 4 |
Amazon
AMZN
|
$200M |
| 5 |
Microsoft
MSFT
|
$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$293M |
| 3 |
Kellanova
K
|
$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.95% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
CareCloud
CCLD
$156M
| $21K | ﹤0.01% |
15,096
| – | – |
|
3302
Cocrystal Pharma
COCP
$15.4M
| $20.7K | ﹤0.01% |
14,596
-419
| -3% | -$595 |
|
3303
US Energy Corp
USEG
$39.8M
| $20.7K | ﹤0.01% |
+17,260
| New | +$20.7K |
|
3304
Immuneering
IMRX
$255M
| $20.4K | ﹤0.01% |
13,366
| – | – |
|
3305
Marker Therapeutics
MRKR
$11.6M
| $19.6K | ﹤0.01% |
15,900
| – | – |
|
3306
Vince Holding
VNCE
$19.4M
| $19.3K | ﹤0.01% |
+10,049
| New | +$19.3K |
|
|
VIGL
3307
DELISTED
Vigil Neuroscience
VIGL
| $19.1K | ﹤0.01% |
+10,704
| New | +$19.1K |
|
3308
Lineage Cell Therapeutics
LCTX
$279M
| $18.3K | ﹤0.01% |
40,449
| – | – |
|
3309
Lazydays
GORV
$10.6M
| $16.5K | ﹤0.01% |
50,551
-4,256
| -8% | -$1.39K |
|
3310
IRIDEX
IRIX
$22.6M
| $14.4K | ﹤0.01% |
14,549
-9,889
| -40% | -$9.79K |
|
3311
Ring Energy
REI
$219M
| $13.1K | ﹤0.01% |
11,409
| – | – |
|
3312
Repare Therapeutics
RPTX
$73M
| $13.1K | ﹤0.01% |
13,265
| – | – |
|
3313
Century Therapeutics
IPSC
$41.1M
| $12.8K | ﹤0.01% |
26,735
-139
| -0.5% | -$67 |
|
|
UBX
3314
DELISTED
Unity Biotechnology
UBX
| $11.6K | ﹤0.01% |
+11,120
| New | +$11.6K |
|
3315
PEDEVCO
PED
$56.6M
| $8.89K | ﹤0.01% |
12,700
| – | – |
|
|
IAUX
3316
i-80 Gold Corp
IAUX
$671M
| $8.67K | ﹤0.01% |
+14,900
| New | +$8.67K |
|
3317
Village Farms International
VFF
$306M
| $7.49K | ﹤0.01% |
12,380
| – | – |
|
3318
Lyell Immunopharma
LYEL
$219M
| $7.24K | ﹤0.01% |
13,463
| – | – |
|
3319
NextCure
NXTC
$13.2M
| $5.85K | ﹤0.01% |
12,175
-73,678
| -86% | -$35.4K |
|
3320
Ovid Therapeutics
OVID
$87.5M
| $3.34K | ﹤0.01% |
10,719
-82,252
| -88% | -$25.7K |
|
3321
Noodles & Co
NDLS
$32M
| – | – |
-26,504
| Closed | -$15.3K |
|
|
AFMD
3322
DELISTED
Affimed
AFMD
| – | – |
-18,120
| Closed | -$21.6K |
|
|
ALLK
3323
DELISTED
Allakos
ALLK
| – | – |
-89,998
| Closed | -$109K |
|
3324
ALX Oncology
ALXO
$55.2M
| – | – |
-26,233
| Closed | -$43.8K |
|
3325
Sphere 3D
ANY
$17.3M
| – | – |
-31,639
| Closed | -$29.9K |
|